/PRNewswire/ -- The American College of Clinical Pharmacology® (ACCP) emphasizes the importance of evidence-based vaccine education in its public policy... WASHINGTON, Oct. 29, 2026 /PRNewswire/ -- The American College of Clinical Pharmacology® (ACCP) emphasizes the importance of evidence-based vaccine education in its public policy…
©UNICEF Ethiopia, Tsegaye / Flickr cc A new study suggests that among the strategies to combat global antibiotic resistance, childhood vaccines may provide the most bang for the buck. The study, published yesterday in Nature, found that pneumococcal conjugate vaccines and…
[Delivered at National Institutes of Health at special event at which the vaccine injured spoke first.] By caring for and consulting on more than 600 children with autism from 5 countries and 20 states, and hundreds of children with complex chronic illnesses, I…
If you’ve ever left a doctor’s office feeling like no one believed you, a new federal research effort may matter to you. In October, the National Institutes of Health (NIH) announced the Vaccinology and Immunology Center. The study will examine…
Changes to federal hepatitis B vaccination recommendations could lead to more childhood infections and leave up to 1.8 million young adults vulnerable to the virus, a new study finds. It comes as health experts raise concerns about the potential long-term impact…
A new national poll reveals strong support for familiar childhood vaccines. Still, partisan divisions, confusion over vaccine schedules, and renewed fears about COVID-19 shots during pregnancy highlight growing challenges for public health messaging. Study: KFF Tracking Poll on Health Information…
On October 8th, under Sec. RFK, Jr., the NIH launched a series of actions to improve research, reporting, and patient care on vaccine injuries. For years, families from numerous countries have complained of vaccine injuries. But their cases are poorly compensated…
A 401-infant presentation compared immune responses and safety with Prevnar 20; the company has not dated its pediatric Phase 3 readout. Antibody responses against 25 pneumococcal strains supported a broader infant vaccine as Pfizer Inc. NYSEPFE presented detailed Phase 2 results on Oct. 24. The…
These data support the ongoing Phase 3 development program for 25vPnC, which, if successful, could help provide protection against serotypes collectively responsible for approximately 84% of invasive pneumococcal disease (IPD) cases among children under five years of age in the U.S.2 - Annaliesa Anderson, Ph.
Investigational vaccine shows strong immune responses in infants equivalent to PREVNAR 20® on shared serotypes and for five new serotypes, potentially offering the broadest protection against invasive pneumococcal disease (IPD) for pediatric population in the U.S. These data support the…
Mental health, risk behaviors, sexual health, and transitions to adult care.
An article joins this feed when it matches these terms. Each one is also a search of its own.